| 1. |
Ghrelin data reviewed |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 2. |
News in brief ... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 3. |
UK NICE guidance on bupropion, NRT for smoking cessation |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 4. |
Hepatitis A vaccination in HCV infection cost effective in the US? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 5. |
Carvedilol less costly than metoprolol in patients with HF |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 6. |
Nitroglycerin beats sphincterotomy for chronic anal fissures |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 7-8
Mark Greener,
Preview
|
|
摘要:
Nitroglycerin [glyceryl trinitrate] is less costly than lateral internal sphincterotomy as a first-line treatment for chronic anal fissures, while offering comparable efficacy, according to a new study.1The analysis could further encourage the move from surgery to pharmacology in this common and painful condition. Chronic anal fissure arises from hypertonia of the internal anal sphincter. Alleviating hypertonia increases blood supply to the sphincter, promoting fissure healing. Although sphincterotomy is often effective, the operation can lead to complications, particularly incontinence.2The increasing recognition of the morbidity associated with lateral internal sphincterotomies helped drive management of chronic anal fissures from surgery toward pharmacological interventions, such as nitroglycerin ointment, over the last decade or so. Indeed, the number of lateral internal sphincterotomies performed in the UK and funded by the National Health Service (NHS) almost halved from 10 000 to 5500 procedures between 1996/1997 and 1999/2000.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 7. |
News in brief ... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 8. |
News in brief ... |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 9. |
Escitalopram has potential in anxiety disorders |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 11-12
Bruce Sylvester,
Preview
|
|
摘要:
The selective serotonin reuptake inhibitor (SSRI), escitalopram [S-citalopram; 'Lexapro', 'Cipralex'], is effective in the treatment of generalised and social anxiety disorders, and panic disorder, according to results from three studies presented at the 22nd Annual Meeting of the Anxiety Disorders Association of America (ADAA) [Austin, US; March 2002]. In separate studies, escitalopram was shown to significantly improve disease-related scores, relative to baseline values and compared with placebo-treated patients.1
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
| 10. |
NSAIDs after acute MI in elderly patients |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1335,
2002,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
首页
